Does LONAPEGSOMATROPIN-TCGD Cause Off label use? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Off label use have been filed in association with LONAPEGSOMATROPIN-TCGD. This represents 3.7% of all adverse event reports for LONAPEGSOMATROPIN-TCGD.
17
Reports of Off label use with LONAPEGSOMATROPIN-TCGD
3.7%
of all LONAPEGSOMATROPIN-TCGD reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From LONAPEGSOMATROPIN-TCGD?
Of the 17 reports, 1 (5.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LONAPEGSOMATROPIN-TCGD. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does LONAPEGSOMATROPIN-TCGD Cause?
Product dose omission issue (91)
Headache (52)
Device use error (40)
Injection site pain (39)
Device malfunction (29)
Treatment noncompliance (25)
Therapy interrupted (24)
Nausea (21)
Vomiting (20)
Fatigue (17)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LONAPEGSOMATROPIN-TCGD Alternatives Have Lower Off label use Risk?
LONAPEGSOMATROPIN-TCGD vs LONCASTUXIMAB TESIRINE-LPYL
LONAPEGSOMATROPIN-TCGD vs LOPERAMIDE
LONAPEGSOMATROPIN-TCGD vs LOPINAVIR
LONAPEGSOMATROPIN-TCGD vs LOPINAVIR\RITONAVIR
LONAPEGSOMATROPIN-TCGD vs LOPRAZOLAM